title: [Immunological mechanisms of allergen-specific immunotherapy].
abstract: Allergen-specific immunotherapy is accompanied by multiple changes on the cellular and humoral level. A shift of Th2 immune responses towards immune responses of the Th1 type, which goes along with an increase of regulatory T cells and B cells, IL-10 as well as reduction of effector cells and eosinophils in the tissue, combined with lower IgE production in favor of higher IgG4 production, are regarded as key mechanisms of allergen-specific immunotherapy . A better understanding of immunologic pathways of specific immunotherapy would be essential for the improvement of this therapy as well as for the development of reliable biomarkers capable to monitor therapeutic responses as well as compliance of the patients.
authors.affiliation: Klinik und Poliklinik für Dermatologie und Allergologie, Universitätsklinikum Bonn, Sigmund-Freud-Str. 25, 53105, Bonn, Deutschland.
authors.forename: J-P
authors.initials: JP
authors.lastname: Allam
authors.affiliation: Klinik und Poliklinik für Dermatologie und Allergologie, Universitätsklinikum Bonn, Sigmund-Freud-Str. 25, 53105, Bonn, Deutschland. Natalija.Novak@ukb.uni-bonn.de.
authors.forename: N
authors.initials: N
authors.lastname: Novak
mesh_terms: D000485:Allergens / Q000276:immunology* / Q000627:therapeutic use*; D000818:Animals; D003888:Desensitization, Immunologic / Q000379:methods*; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology* / Q000628:therapy*; D056724:Immunity, Humoral / Q000276:immunology; D007962:Leukocytes / Q000276:immunology*; D018448:Models, Immunological
chemical_list: D000485:Allergens
keywords: Biomarker; Compliance; Immune response; Tolerance; Type I allergy